Once-daily RELEXXII extended-release tablets provide a steady, more consistent effect, reducing the highs and lows associated with taking immediate-release methylphenidate HCI three times daily.1
This graph is for illustrative purposes only. It is based on 54 mg pharmacokinetic data from a study of 36 healthy participants aged 18-65.2,3 Individual responses, including the timing of drug absorption, drug concentration levels, and duration of effect, may vary.